CONMED (NYSE: CNMD) — Perfil da empresa, notícias e dados financeiros
CONMED focuses on medical technology, offering surgical devices and solutions for enhanced clinical outcomes.
CONMED
CONMED (NYSE:CNMD) focuses on medical technology with a wide range of products geared towards surgery and patient monitoring. It's traded on the New York Stock Exchange under the ticker symbol NYSE:CNMD. Specializing in both single-use and reusable surgical devices, CONMED's portfolio includes electrosurgical systems, endoscopic technologies, and orthopedic arthroscopy equipment. The company’s projects often revolve around developing innovative solutions that improve clinical outcomes for patients and enhance the capabilities of healthcare professionals globally. CONMED aims to continue expanding its product line through research and development, as well as strategic acquisitions, to cater to the evolving needs of the medical community while maintaining high standards of quality and safety.
Resumo
Operações
Produtos e/ou serviços de CONMED
- Surgical devices and equipment for minimally invasive procedures, enhancing operational efficiency and patient outcomes.
- Orthopedic surgery tools, specializing in sports medicine and reconstructive technologies.
- Advanced patient monitoring systems, ensuring precise vital signs monitoring during surgical procedures.
- Electrosurgical units and accessories, offering precision and control for various surgical applications.
- Endoscopic technologies, providing innovative solutions for gastrointestinal and pulmonary diagnosis and procedures.
- Biomedical research and development services, focused on creating cutting-edge medical devices and technologies.
equipe executiva do CONMED
- Patrick J. BeyerPresident, CEO & Director
- Hollie K. FoustExecutive VP, General Counsel & Corporate Secretary
- Peter K. ShagoryExecutive Vice President of Strategy & Corporate Development
- Todd W. GarnerAdvisor
- Brent LalomiaExecutive VP of Regulatory Affairs, Quality Assurance, Clinical Affairs, Commercial Operations & IT
- John E. Gallagher IIIExecutive VP, CFO and Principal Financial & Accounting Officer
- Josep Lluis LlorensExecutive VP Global Supply Chain Management & Operations
- Richard GlazeChief Information Officer
- Keith SeatonVice President of Compliance
- John David FerrellExecutive Vice President of Human Resources
Histórico de dividendos
Dividendos por ação pagos pela CONMED , por ano fiscal.
| Ano fiscal | Intermediário | Final | Especial | Total |
|---|---|---|---|---|
| FY2025 | — | — | — | $0.6000 |
| FY2024 | — | — | — | $0.8000 |
| FY2023 | — | — | — | $0.8000 |
| FY2022 | — | — | — | $0.8000 |
| FY2021 | — | — | — | $0.8000 |
Principais indicadores financeiros
Resultados divulgados pela CONMED , em USD.
- Cap. de mercado
- 1,4 bi
- Receita (TTM)
- 1,4 bi
- P/L
- 26.4
- LPA (diluído, TTM)
- 1.8
- Dividend yield
- —
- Margem de lucro
- 4.1%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 1,4 bi | 141,1 mi | 47,1 mi | |
| 1,3 bi | 200,3 mi | 132,4 mi | |
| 1,2 bi | 120,6 mi | 64,5 mi | |
| 1 bi | 70,1 mi | -80,6 mi |